Significant linkage to spondyloarthropathy on 9q31-34

Human Molecular Genetics

Volumn 13, Issue 15, 2004, Pages 1641-1648

  Miceli Richard, Corinne ^a,b   Zouali, Habib ^a   Said Nahal, Roula ^b   Lesage, Suzanne ^a   Merlin, Françoise ^a   de Toma, Claudia ^a   Blanche, Hélène ^a   Sahbatou, Mourad ^a   Dougados, Maxime ^b   Thomas, Gilles ^a   Breban, Maxime ^c   Hugot, Jean Pierre ^a,d   D'Agostino, Maria Antonietta ^b   Amor, Bernard ^b   Berthelot, Jean Marie ^e   Saraux, Alain ^f   Perdriger, Aleth ^g   Guis, Sandrine ^h   Puechal, Xavier ⁱ   Maillefert, Jean Françis ^j   Combe, Bernard ^k   Claudepierre, Pascal ^l   Sibilia, Jean ^m   more..

^a FONDATION JEAN DAUSSET CEPH   (France)

^b Universite Rene Descartes ^*  (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f SERVICE DE RHUMATOLOGIE   (France)

^g RENNES UNIVERSITY HOSPITAL   (France)

^h APHM and UMR S1076   (France)

ⁱ CENTRE HOSPITALIER DU MANS   (France)

^j GENERAL HOSPITAL   (France)

^k LAPEYRONIE HOSPITAL   (France)

^l HENRI MONDOR HOSPITAL   (France)

^m HÔPITAL DE HAUTEPIERRE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTHRITIS; ARTICLE; CAUCASIAN; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 5Q; CHROMOSOME 9Q; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; FREQUENCY ANALYSIS; GENE MAPPING; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; OUTCOMES RESEARCH; PATHOGENESIS; PHYSICAL DISABILITY; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SPONDYLOARTHROPATHY; WESTERN EUROPE;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HAPLOTYPES; HUMANS; LOD SCORE; MICROSATELLITE REPEATS; PEDIGREE; SPONDYLARTHROPATHIES;

EID: 4344652261     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh179     Document Type: Article

References (39)

1. Saraux, A., Guedes, C., Allain, J., Devauchelle, V., Valls, I., Lamour, A., Guillemin, F., Youinou, P. and Le Goff, P. (1999) Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Societe de Rhumatologie de l'Ouest. J. Rheumatol., 26, 2622-2627.
2. Said-Nahal, R., Miceli-Richard, C., Berthelot, J.M., Duche, A., Dernis-Labous, E., Le Blevec, G., Saraux, A., Perdriger, A., Guis, S., Claudepierre, P. et al. (2000) The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Francais d'Etude Genetique des Spondylarthropathies. Arthritis Rheum., 43, 1356-1365.
3. Said-Nahal, R., Miceli-Richard, C., D'Agostino, M.A., Dernis-Labous, E., Berthelot, J.M., Duche, A., Le Blevec, G., Saraux, A., Perdriger, A., Guis, S. et al. (2001) Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy. Arthritis Rheum., 45, 478-484.
4. Brewerton, D.A., Hart, F.D., Nicholls, A., Caffrey, M., James, D.C. and Sturrock, R.D. (1973) Ankylosing spondylitis and HL-A 27. Lancet, 1, 904-907.
5. Schlosstein, L., Terasaki, P.I., Bluestone, R. and Pearson, C.M. (1973) High association of an HL-A antigen, W27, with ankylosing spondylitis. N. Engl. J. Med., 288, 704-706.
6. Hammer, R.E., Maika, S.D., Richardson, J.A., Tang, J.P. and Taurog, J.D. (1990) Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell, 63, 1099-1112.
7. Jarvinen, P. (1995) Occurrence of ankylosing spondylitis in a nationwide series of twins. Arthritis Rheum., 38, 381-383.
8. Brown, M.A., Kennedy, L.G., MacGregor, A.J., Darke, C., Duncan, E., Shatford, J.L., Taylor, A., Calin, A. and Wordsworth, P. (1997) Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum., 40, 1823-1828.
9. van der Linden, S.M., Valkenburg, H.A., de Jongh, B.M. and Cats, A. (1984) The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum., 27, 361-368.
10. van der Linden, S.M. and Khan, M.A. (1984) The risk of ankylosing spondylitis in HLA-B27 positive individuals: a reappraisal. J. Rheumatol., 11, 727-728.
11. Laval, S.H., Timms, A., Edwards, S., Bradbury, L., Brophy, S., Milicic, A., Rubin, L., Siminovitch, K.A., Weeks, D.E., Calin, A. et al. (2001) Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am. J. Hum. Genet., 68, 918-926.
12. Breban, M., Said-Nahal, R., Hugot, J.P. and Miceli-Richard, C. (2003) Familial and genetic aspects of spondyloarthropathy. Rheum. Dis. Clin. North Am., 29, 575-594.
13. Brown, M.A., Edwards, S., Hoyle, E., Campbell, S., Laval, S., Daly, A.K., Pile, K.D., Calin, A., Ebringer, A., Weeks, D.E. and Wordsworth, B.P. (2000) Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum. Mol. Genet., 9, 1563-1566.
14. Tsui, F.W., Tsui, H.W., Cheng, E.Y., Stone, M., Payne, U., Reveille, J.D., Shulman, M.J., Paterson, A.D. and Inman, R.D. (2003) Novel genetic markers in the 5′-flanking region of ANKH are associated with ankylosing spondylitis. Arthritis Rheum., 48, 791-797.
15. McGarry, F., Neilly, J., Anderson, N., Sturrock, R. and Field, M. (2001) A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford), 40, 1359-1364.
16. Maksymowych, W.P., Reeve, J.P., Reveille, J.D., Akey, J.M., Buenviaje, H., O'Brien, L., Peloso, P.M., Thomson, G.T., Jin, L. and Russell, A.S. (2003) High-throughput single-nucleotide polymorphism analysis of the IL1RN locus in patients with ankylosing spondylitis by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Arthritis Rheum., 48, 2011-2018.
17. Brown, M.A., Pile, K.D., Kennedy, L.G., Campbell, D., Andrew, L., March, R., Shatford, J.L., Weeks, D.E., Calin, A. and Wordsworth, B.P. (1998) A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum., 41, 588-595.
18. Lander, E. and Kruglyak, L. (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet., 11, 241-247.
19. Altmuller, J., Palmer, L.J., Fischer, G., Scherb, H. and Wjst, M. (2001) Genomewide scans of complex human diseases: true linkage is hard to find. Am. J. Hum. Genet., 69, 936-950.
20. van der Linden, S., Valkenburg, H.A. and Cats, A. (1984c) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum., 27, 361-368.
21. Amor, B., Dougados, M. and Mijiyawa, M. (1990) Critère diagnostique des spondylarthropathies. Rev. Rhum. Mal. Osté oartic., 57, 85-89.
22. Dougados, M., Van der Linden, S., Juhlin, R., Huitfeldt, B., Amor, B., Calin, A., Cats, A., Dijkmans, B., Olivieri, I., Pasero, G. et al. (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum., 34, 1218-1227.
23. Collantes, E., Veroz, R., Escudero, A., Munoz, E., Munoz, M.C., Cisnal, A. and Perez, V. (2000) Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spondyloarthropathies. Spanish Spondyloarthropathy Study Group. Joint Bone Spine, 67, 516-520.
24. Wordsworth, P. (1998) Genes in the spondyloarthropathies. Rheum. Dis. Clin. North Am., 24, 845-863.
25. Rioux, J.D., Daly, M.J., Silverberg, M.S., Lindblad, K., Steinhart, H., Cohen, Z., Delmonte, T., Kocher, K., Miller, K., Guschwan, S. et al. (2001) Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet., 29, 223-228.
26. Tomfohrde, J., Silverman, A., Barnes, R., Fernandez-Vina, M.A., Young, M., Lory, D., Morris, L., Wuepper, K.D., Stastny, P., Menter, A. and Bowcock, A.M. (1994) Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science, 264, 1141-1145.
27. Nair, R.P., Henseler, T., Jenisch, S., Stuart, P., Bichakjian, C.K., Lenk, W., Westphal, E., Guo, S.W., Christophers, E., Voorhees, J.J. and Elder, J.T. (1997) Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum. Mol. Genet., 6, 1349-1356.
28. Enlund, F., Samuelsson, L., Enerback, C., Inerot, A., Wahlstrom, J., Yhr, M., Torinsson, A., Riley, J., Swanbeck, G. and Martinsson, T. (1999) Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden. Eur. J. Hum. Genet., 7, 783-790.
29. Brown, M.A., Brophy, S., Bradbury, L., Hamersma, J., Timms, A., Laval, S., Cardon, L., Calin, A. and Worsworth, P. (2003) Dentification of major loci controlling clinical manifestations of ankylosing spondylitis. Arthritis Rheum., 48, 2234-2239.
30. Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C. et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 282, 2085-2088.
31. Chow, J.C., Young, D.W., Golenbock, D.T., Christ, W.J. and Gusovsky, F. (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem., 274, 10689-10692.
32. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411, 599-603.
33. Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R. and Duerr R.H. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411, 603-606.
34. Speiser, D.E., Lee, S.Y., Wong, B., Arron, J., Santana, A., Kong, Y.Y., Ohashi, P.S. and Choi, Y. (1997) A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J. Exp. Med., 185, 1777-1783.
35. Kashii, Y., Giorda, R., Herberman, R.B., Whiteside, T.L. and Vujanovic, N.L. (1999) Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J. Immunol., 163, 5358-5366.
36. Aizawa, S., Nakano, H., Ishida, T., Horie, R., Nagai, M., Ito, K., Yagita, H., Okumura, K., Inoue, J. and Watanabe, T. (1997) Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation. J. Biol. Chem., 272, 2042-2045.
37. Willkens, R.F., Arnett, F.C., Bitter, T., Calin, A., Fisher, L., Ford, D.K., Good, A.E. and Masi, A.T. (1981) Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum., 24, 844-849.
38. Lander, E.S. and Green, P. (1987) Construction of multilocus genetic linkage maps in humans. Proc. Natl Acad. Sci. USA, 84, 2363-2367.
39. Kruglyak, L., Daly, M.J., Reeve-Daly, M.P. and Lander, E.S. (1996) Parametric and nonparametric linkage analysis: unified multipoint approach. Am. J. Hum. Genet., 58, 1347-1363.